Clinical Trial Update: Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared With Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing albumin-bound interferon alfa-2b plus ribavirin versus pegylated interferon alfa-2a plus ribavirin in interferon-naive patients with c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Albumin Interferon Alfa-2b with Ribavirin (Interferon alfa-2b (albumin-bound) with ribavirin)
• Peg-IFN Alfa-2a with Ribavirin (Pegylated Interferon alfa-2a (Peg-IFN alfa-2a) with ribavirin)

Snippet

Sponsor: Human Genome Sciences Inc. | Conditions: Chronic Hepatitis C | Phase 3 | Status: COMPLETED